Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer

Heparanase (HPSE), an endoglycosidase that cleaves heparan sulfate, regulates a variety of biological processes that promote tumor progression. In this study, we analyzed the correlation between HPSE expression and prognosis in cancer patients, using multiple databases (Oncomine, TIMER, PrognoScan,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wen-Jing, Shi, Lin, Wang, Xiao-Min, Yang, Guo-Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436937/
https://www.ncbi.nlm.nih.gov/pubmed/34461608
http://dx.doi.org/10.18632/aging.203489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436937/
https://www.ncbi.nlm.nih.gov/pubmed/34461608
http://dx.doi.org/10.18632/aging.203489

Ejemplares similares